We have previously observed that EpCAM+ CD44+ CD90+ breast carcinoma cells in a metastatic pleural effusion survived preferentially after palliative chemotherapy.20 It is therefore of great importance to determine whether this same phenotypic population, when isolated from the blood, is tumorigenic. The gene discussed is CD44; the disease is breast carcinoma.